In recent months a spate of mutations have been found in a disease protein called TDP-43 that is implicated in two neurodegenerative disorders: amyotrophic lateral sclerosis, also called Lou Gehrig's disease, and certain types of frontotemporal dementia.

These mutations could potentially become candidates for drug targets. Recently, scientists have found two more mutations.